| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 884-888, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
JA DiGiuseppe, MS Redston, CJ Yeo, SE Kern and RH Hruban
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-6417, USA.
The p53 tumor suppressor gene is mutated in the majority of pancreatic adenocarcinomas, and several studies have suggested that loss of p53 function may contribute to the aggressive clinical behavior of pancreas cancer. Although immunocytochemical accumulation of the p53 gene product has previously been assessed as a marker for p53 mutations in cancers of the pancreas and other organ systems, the relationship between p53 mutations and p53 protein accumulation is variable. The cyclin-dependent kinase inhibitor, p21 (also known as WAF1 and CIP1), is induced by wild-type but not mutant p53, and recent work has implicated p21 as a downstream mediator of the growth-suppressing and apoptosis-promoting functions of wild-type p53. In the present work, we sought to determine whether loss of p21 expression could more precisely identify those tumors with p53 mutations and/or loss, compared with immunocytochemical assessment of p53 protein accumulation. We evaluated p53 and p21 expression immunohistochemically in a series of 21 ductal adenocarcinomas of the pancreas with known p53 mutational status. Diffuse overexpression of p53 was found in 3 of 8 cases (38%) with wild- type p53 and 7 of 13 cases (54%) with p53 mutations with or without loss of heterozygosity at 17p. Surprisingly, expression of p21 correlated neither with p53 mutational status nor with p53 protein expression. In particular, strong p21 expression was seen even in carcinomas in which molecular analysis revealed a frameshift mutation in one allele of p53 and loss of the second. These data suggest that p21 expression in pancreatic adenocarcinoma may also be induced by a p53-independent pathway and that p21 expression, as assessed immunocytochemically, does not reflect the functional status of p53 in these carcinomas.
This article has been cited by other articles:
![]() |
A. M. Ab' Saber, L. M. Massoni Neto, C. P. Bianchi, B. B. Ctenas, E. R. Parra, E. M. Eher, J. C. Pereira, T. Takagaki, N. H. Yamaguchi, and V. L. Capelozzi Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Ann. Thorac. Surg., June 1, 2004; 77(6): 1883 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kahnt, K. Matz-Rensing, P. Hofmann, C. Stahl-Hennig, and F.-J. Kaup SIV-associated Lymphomas in Rhesus Monkeys (Macaca mulatta) in Comparison with HIV-associated Lymphomas Vet. Pathol., January 1, 2002; 39(1): 42 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Biankin, J. G. Kench, A. L. Morey, C.-S. Lee, S. A. Biankin, D. R. Head, T. B. Hugh, S. M. Henshall, and R. L. Sutherland Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia Cancer Res., December 1, 2001; 61(24): 8830 - 8837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Schwerer, A Sailer, K Kraft, K Baczako, and H Maier Patterns of p21waf1/cip1 expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas J. Clin. Pathol., November 1, 2001; 54(11): 871 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsutani, A. Yamauchi, R. Takahashi, M. Ueno, K. Yoshikawa, K. Honda, H. Nakamura, H. Kato, H. Kodama, T. Inamoto, et al. Inverse Correlation of Thioredoxin Expression with Estrogen Receptor- and p53-dependent Tumor Growth in Breast Cancer Tissues Clin. Cancer Res., November 1, 2001; 7(11): 3430 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mouriaux, C.-A. Maurage, P. Labalette, B. Sablonnière, F. Malecaze, and J.-M. Darbon Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2837 - 2843. [Abstract] [Full Text] |
||||
![]() |
G. Pruneri, L. Pignataro, N. Carboni, R. Buffa, D. Di Finizio, B. M. Cesana, and A. Neri Clinical Relevance of Expression of the CIP/KIP Cell-Cycle Inhibitors p21 and p27 in Laryngeal Cancer J. Clin. Oncol., October 1, 1999; 17(10): 3150 - 3159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Saunders, R. MacKenzie, R. Shipman, E. Fransen, R. Gilbert, and R. C. K. Jordan Patterns of p53 Gene Mutations in Head and Neck Cancer: Full-Length Gene Sequencing and Results of Primary Radiotherapy Clin. Cancer Res., September 1, 1999; 5(9): 2455 - 2463. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. CHIAO, K. K. HUNT, A. M. GRAU, A. ABRAMIAN, J. FLEMING, W. ZHANG, T. BRESLIN, J. L. ABBRUZZESE, and D. B. EVANS Tumor Suppressor Gene Smad4/DPC4, Its Downstream Target Genes, and Regulation of Cell Cycle Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 31 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshikawa, K. Honda, T. Inamoto, H. Shinohara, A. Yamauchi, K. Suga, T. Okuyama, T. Shimada, H. Kodama, S. Noguchi, et al. Reduction of BRCA1 Protein Expression in Japanese Sporadic Breast Carcinomas and Its Frequent Loss in BRCA1-associated Cases Clin. Cancer Res., June 1, 1999; 5(6): 1249 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shoji, Y. Dobashi, S. Morinaga, S.-X. Jiang, and T. Kameya Tumor Extension and Cell Proliferation in Adenocarcinomas of the Lung Am. J. Pathol., March 1, 1999; 154(3): 909 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputi, V. Esposito, A. Baldi, A. De Luca, C. Dean, G. Signoriello, F. Baldi, and A. Giordano p21waf1/cip1mda-6 Expression in Non-small-cell Lung Cancer: Relationship to Survival Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 213 - 217. [Abstract] [Full Text] |
||||
![]() |
B. A. Jones and G. J. Gores Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |